MACE

·MeSH: Heart Failure

7 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
sodium oxybate	Nascent Biotech Inc. (NBIO)
TechneLite	Lantheus Holdings, Inc. (LNTH)

Phase 1(1)

Drug	Company
EphA2 (BRC)	BICYCLE THERAPEUTICS PLC (BCYC)

Preclinical(3)

Drug	Company
MT1-MMP	BICYCLE THERAPEUTICS PLC (BCYC)
terpene synthesis	EXOZYMES INC. (EXOZ)
Undisclosed	BICYCLE THERAPEUTICS PLC (BCYC)

Unknown(1)

Drug	Company
clonoSEQ assay (MRD Pharma)	Adaptive Biotechnologies Corp (ADPT)

BioSniper tracks 7 drugs in development for MACE across 5 companies.

There are 1 clinical trial targeting MACE tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.